See if you can read the following for comprehension, you

New Post Public Reply Private Reply Replies (1) Message Board
Bhawks dbergh #98901
211
See if you can read the following for comprehension, you dumb shit.

Short take, Trump be the one who is f'd.

IMO, this documents story will be over pretty quickly (for Biden, not Trump)

First of all I gotta say I don't really get the handwringing over the special counsel appointment. The Justice Department was investigating Trump's mishandling of classified documents while he was a private citizen, and three days after Trump announced he was running for president again, Garland appointed a special counsel. Because as soon as he announced, he stopped being a regular private citizen and became a presidential candidate.

Similarly, when the news broke that classified documents had turned up at a couple of Biden properties, Garland immediately appointed a special counsel. Because Biden isn't a regular private citizen, he's the president.

Appointing special counsels in both cases does a LOT to prevent the Republican House from interfering with either investigation. The special counsels can't be dragged to hearings and made to talk about the investigations. Neither the House, nor the AG, can interfere with either investigation.

So what's going to turn up here? In Biden's case, it's most likely going to end up being a simple error.

Documents were filed incorrectly at the end of Obama's presidency and some of them ended up where they shouldn't be. As soon as they were discovered, Biden's lawyers contacted the National Archives so that they could be recovered. They also immediately cooperated with further searches, which turned up a few other misfiled documents.

At every step of the way, Biden and his people cooperated with law enforcement and the National Archives.
As soon as the documents were discovered, they went out of their way to make sure that they were recovered correctly, and that no more we missing.

So what is there for the special counsel to really investigate here? They'll look into how the documents got there in the first place, and they'll probably determine that ultimately some staffer packed some papers into a box that they shouldn't have.

Sure, the GOP will do all they can to make hay out of it. But this could end up being a relatively short-lived story -- it's not like the presidential election is two weeks away, when a story like this really COULD make a big difference (see: James Comey, Hillary Clinton).

The big news is that the special counsel was appointed in the first place. Once the excitement over the announcement has passed, the investigation goes quiet and there's nothing for cable news to bite on. The news cycle will move on to the next thing.

Then at some point down the road, the special counsel will release a report saying that someone somewhere mishandled documents but it wasn't done on purpose and no charges will be filed. End of story.

The point is that I don't think there's much to be afraid of here, since it will probably turn out to be a big nothingburger. (And to be clear, if it's NOT a nothingburger -- if Biden deliberately stole those documents and hid them on purpose so he could misuse them in future -- then that's a real problem and we should know about it. But does anyone believe that's actually what happened?)

Trump, however, is in a very different position. He knew he had the documents, he kept them purposefully, he refused to turn them over to the National Archives -- claiming that they belonged to him -- and after the National Archives negotiated with him to turn the documents over, he deliberately withheld additional documents. Given the serious possibility of obstruction of justice, Trump's special counsel investigation may not end well for him.

Either way, while the media is trying to spin this up as a major political disaster for Joe Biden, it seems to me that barring any unexpected bombshells, this story will be fixated on in the very short term and then forgotten about in a few months.

https://www.democraticunderground.com/100217556827

14. Jack Smith is looking into more than the theft of classified documents.

Garland knew about the stolen documents 2 years ago some of which involved sources and methods, some of which involved military nuclear weapons. Garland without a doubt treated Trump with kid gloves, allowing the National Archives to investigate until it had to refer the matter back to DOJ.

I will not repeat how DOJ gave Trump so many numerous chances to return what he had stolen until there was no other choice but to get a search warrant and still Trump obstructed and hid more documents.

I disagree with the comparisons between the 2 special counsels, one should have happened 2 years ago and the other one didn't meet the guidelines for having one.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

WEPSEA 2026 Propels Southeast Asia's Packaging Leap

Updated Category News Views 1

Revolution in Packaging: Southeast Asia Steps Up Get ready for a wake-up call in the world of packaging, folks; the Southeast Asian market is taking a sharp turn toward sustainability and technological advancement, as highlighted by WEPSEA 2026's recent wrap-up in Shanghai. Far from a mere exhibition, this gathering served as the crucible for change, where old-school...

Continue Reading
DUVA ONE Sleep Earbuds: Real-Time Innovation Debuts

Updated Category News Views 3

While You Dream, DUVA ONE Works Here's the scoop: DUVA just took sleep tech to another level with their DUVA ONE earbuds launched at Berlin's IFA 2026. These aren't just any earbuds; they're engineered to actually do something while you're sleeping. DUVA ONE senses what’s happening during your snooze session and adjusts right on the fly. The Night Patrol: In-Ear and...

Continue Reading
Clover's RSV Combo Vaccine Shows Promise in Trials

Updated Category News Views 3

In the biotech world, there's always a race. Clover Biopharmaceuticals is making strides with their RSV+hMPV vaccine candidate, especially for the elderly. Imagine those big leaps in development—all boosted by recent results from a Phase 2 trial down under in Australia. Key Findings of the Trial Immunogenicity Insights They're not messing around with these findings. The...

Continue Reading
Changhong's IFA 2026 Showcase: AI, Culture & Localization

Updated Category News Views 4

Changhong's Game Plan: From Global Reach to Local Touch Well, Changhong's not sitting back at IFA 2026, let me tell you that. This isn't your run-of-the-mill showcase; it's a full-on reveal of what happens when a company takes AI tech and tunes it to the heartbeat of daily life. TVs, fridges, air conditioners—you name it, they've got an AI twist on it. But is this just...

Continue Reading
Harbour BioMed Joins Stock Connect, Boosts Investor Access

Updated Category News Views 3

The Big Leap: Harbour BioMed Joins Stock Connect Well, if this ain't something to get excited about—Harbour BioMed just snagged a spot on the Stock Connect roster. This step isn't just ceremonial. We're talking about real access for mainland Chinese investors to dive directly into the shares of Harbour BioMed (HKEX: 02142.HK) through the Shanghai-Hong Kong and...

Continue Reading
MERACH Unveils W60 Plus: A Game Changer for Home Fitness

Updated Category News Views 1

MERACH's Ambitious Leap into European Markets Walking is one of life's simple pleasures, but it's not always convenient in our work-from-home driven world. That's where MERACH's UltraWalk W60 Plus comes in, dropping anchor in Europe like a brand new ship with all the bells and whistles. What makes this walking pad different, you ask? It's designed to become a natural...

Continue Reading
Mermaid Folklore Meets Revolution in New Short Film

Updated Category News Views 2

A Sea Haunting Like No Other Ever feel like history's forgotten tales deserve a fresh spin? Well, this one's shaking it up! Hoyt Dwyer, an Atlanta filmmaker, flips the script on a lesser-known bit from the American Revolution. Yeah, we're talking about Hessian soldiers and sirens here. Just hang on to your hats because this ain't your typical historical retelling. A...

Continue Reading
Aroa Biosurgery Reports Low Infection Rates: A Milestone

Updated Category News Views 1

Peer-Reviewed Study: Aroa's Myriad Shows Low Infection Rates Seems like the folks at Aroa Biosurgery have got something solid to brag about in the world of complex soft tissue reconstruction. The company just released interim results from their massive MASTRR Registry study, and the numbers are looking pretty darn promising. We're talking about a 411-patient analysis...

Continue Reading
Softcare Facilitates Standards Delegation Visit to Senegal

Updated Category News Views 3

Ever seen a whole nation's hygiene industry getting a deep dive from not just one, but three major standards bodies? That's what just went down in Senegal. Softcare opened its doors wide to folks from the Senegalese Association for Standardization (ASN), the International Organization for Standardization (ISO), and the Swedish Institute for Standards (SIS). This was no...

Continue Reading

Top 5 Most Recently Viewed Articles

Prinses Máxima Center Enhances Genomics with Callisto™ Innovation

Updated Category News Views 194

Prinses Máxima Center's Partnership with Volta Labs The Prinses Máxima Center for Pediatric Oncology is making headlines with its recent acquisition of the Callisto™ platform from Volta Labs. This major step forward aims to enhance efficiency in sample preparation across a variety of genomics workflows, specifically designed for both Illumina and Oxford Nanopore...

Continue Reading
Boise Hunter Homes Appoints Industry Veteran Julie DeLorenzo

Updated Category News Views 474

Julie DeLorenzo Joins Boise Hunter Homes Boise Hunter Homes welcomes Julie DeLorenzo to its team as the new Director of Community Relations. This strategic move emphasizes the company’s commitment to community building and corporate stewardship. Experience and Community Commitment DeLorenzo comes with extensive experience as an Idaho Realtor, and her dedication to...

Continue Reading
Growth Prospects for Glass Prefilled Syringes in Europe

Updated Category News Views 151

Emerging Trends in the European Market for Glass Prefilled Syringes The market for glass prefilled syringes and vials in Europe is undergoing significant transformations as we witness a rapid development in healthcare and biotechnology sectors. The competitive landscape is shifting, with the adoption of innovative packaging techniques, the rise of biologics as a treatment...

Continue Reading
Man Group PLC Announces Significant Shareholdings Update

Updated Category News Views 112

Clarifying Share Interests of Man Group PLC Understanding the ownership structure in the financial world is crucial for investors. In compliance with the rules set out by the Takeover Code, disclosures regarding significant shareholdings need to be clear and transparent. Recently, Man Group PLC has taken steps to outline its relevant investments, specifically in relation...

Continue Reading
Nutrien Faces Downgrade as UBS Revises Outlook and Price Target

Updated Category News Views 87

UBS Downgrades Nutrien's Rating Amid Agricultural Concerns UBS has recently made headlines by downgrading Nutrien (NYSE: NTR) from a "buy" to a "neutral" rating. This adjustment reflects growing concerns about the agricultural market's performance and the potential impact on the company’s financial health. Weaker Agricultural Market Outlook Analysts at UBS have...

Continue Reading